The Scottish government will increase its New Medicines Fund next year to double the amount of money available to fund …

In England over 55 million patients can now order repeat prescriptions, book GP appointments and access their medical records online …

Amgen has appointed Jonathan Graham as its senior vice president, general counsel and secretary who will take to his post in July. …
Merck KGaA encountered an uneven start to 2015, with robust sales in the first quarter offset by declines in key …

Endo is switching strategies from attempting to buy specialist pharma firms, to generics, having announced a huge $8 billion deal …

AstraZeneca is spending around $285 million on a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The …

UK-based biotech Calchan has looked to Pfizer for appointing a new chief scientific officer in Zahid Ali. Ali has almost …

UK prime minister David Cameron has committed to extra funding for the NHS in his first major speech following the …

The FDA has warned that a class of type 2 diabetes drugs manufactured by several big pharma firms could cause …
Boehringer Ingelheim has highlighted new data for its idiopathic pulmonary fibrosis (IPF) treatment Ofev in a Phase II study on …

Takeda UK has appointed Craig Adkins as the new director of its its inflammatory bowel disease (IBD) business unit. Adkins …

Recent legislation assumes that visual information can have direct effects on people’s behaviour. It starts from the assumption that a …
Merck KGaA is the latest company to announce its slate for this year’s ASCO conference, and like other firms it …

Patients who take either dose of Teva’s investigational treatment for chronic migraine improve more than those taking a placebo according …

King’s College Hospital in London is piloting a scheme whereby cancer patients moving through chemotherapy treatments are given an Apple …

Virgo Health Education has appointed a new head of medical education and announced a number of senior team promotions. Katherine …

An investigational immuno-oncology drug combination from AstraZeneca has shown promise in its most recent trial, although concerns over its side …

Bayer has held on to the top spot in a global survey of how much the general public trusts and …

Roche has revealed promising trial data from two lung cancer treatments with one improving survival and the other shrinking tumours. …

Takeda is threatening to end its partnership with Orexigen to market the obesity drug Contrave, as allegations around its heart …